Lisa Cantagallo

Lisa Cantagallo has over 20 years of experience in the pharmaceutical and clinical research industry. Lisa is currently serving as the Senior Vice President of Clinical Operations at Monte Rosa Therapeutics since September 2021. Prior to this, Lisa held senior positions at H3 Biomedicine, starting as the Director of Clinical Operations in September 2017 and eventually becoming the Sr. Director of Clinical Operations in November 2020.

Before joining H3 Biomedicine, Lisa worked at Acceleron Pharma as the Director of Clinical Operations. In this role, they oversaw various aspects of clinical operations, including vendor management, patient recruitment strategies, and budget management. Lisa also played a key role in developing and maintaining standards across clinical studies within the program.

Earlier in their career, Lisa gained experience at Novartis Institutes for BioMedical Research, Millennium Pharmaceuticals, EPIX Pharmaceuticals, Brigham and Women's Hospital, and The TIMI Study Group, where they held various clinical research and management positions.

Lisa's diverse experience and expertise in clinical operations make their a valuable asset to any organization in the pharmaceutical industry.

Lisa Cantagallo earned a Bachelor of Science (BS) degree in Business Administration and Management from the University of Rhode Island - College of Business. Lisa later obtained a Master of Business Administration (MBA) degree from UMass Boston.